Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Acerca de Lite Strategy

Fundado2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Comunidad
Twitter
Website
Etiquetas
Publicly listed company
Crypto Stocks

Tendencia de cambio del índice de popularidad

Sin registro

Miembros del equipo

Frederick W. Driscoll
Frederick W. Driscoll

Chairperson and Non-Executive Director

Justin (Jay) File
Justin (Jay) File

Chief Executive Officer and Chief Financial Officer

Detalles de la recaudación de fondos

Post-IPO(2025-07-21)
Cantidad€87,78M
Valuación--